The clotting time because of this mixture is weighed against the clotting time of normal plasma then. Tests results, which are often available after a couple of days, are reported seeing that the patient’s %age of the element VIII activity in regular plasma. A minimal %age sometimes appears with hemophilia A, although condition could be mild or severe. Low levels might indicate the current presence of element VIII inhibitors also, which are antibodies that some children with serious hemophilia develop when their bodies respond to the clotting factor seeing that a foreign compound and create antibodies to block its clotting actions.Bristol-Myers Squibb Company Reviews Financial Outcomes for the Fourth One fourth and 2007 Bristol-Myers Squibb Company today reported financial results for the fourth quarter and twelve months ended December 31, 2007 and revised 2008 revenue assistance to reflect the sale of the Medical Imaging business primarily. Bristol-Myers Squibb posted fourth quarter 2007 net product sales from continuing operations of $5.4 billion, an increase of 33 percent, including a 5 percent favorable foreign exchange impact, compared to the same period in 2006. The company reported a fourth one fourth 2007 net loss from continuing procedures of $133 million, or a lack of $0.07 per diluted share, under U.S. Generally Accepted Accounting Principles , in comparison to a net reduction from continuing operations of $170 million, or a loss of $0.09 per diluted share for the same period in 2006.